Published on the 7 November 2016
Evaluating preclinical emesis induced by PDE4 inhibitors via a noradrenergic pathway
Emesis and/or Nausea are commonly reported side effects associated with several drugs such as 4 phosphodiesterase (PDE4) inhibitors and is a major drawback for the therapeutic use of these drugs. The …
Science and innovation
